Active Ingredient: VOXELOTOR
Proprietary Name: OXBRYTA
Dosage Form; Route of Administration: TABLET, FOR SUSPENSION; ORAL
Strength: 300MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N216157
Product Number: 001
Approval Date: Dec 17, 2021
Applicant Holder Full Name: GLOBAL BLOOD THERAPEUTICS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
